Literature DB >> 17047682

Heme oxygenase-1 stabilizes the blood-spinal cord barrier and limits oxidative stress and white matter damage in the acutely injured murine spinal cord.

Yong Lin1, Hendrik J Vreman, Ronald J Wong, Tjoson Tjoa, Toshihiro Yamauchi, Linda J Noble-Haeusslein.   

Abstract

We hypothesized that heme oxygenase (HO)-1, the inducible form of HO, represents an important defense against early oxidative injury in the traumatized spinal cord by stabilizing the blood-spinal cord barrier and limiting the infiltration of leukocytes. To test this hypothesis, we first examined the immunoexpression of HO-1 and compared barrier permeability and leukocyte infiltration in spinal cord-injured HO-1-deficient (+/-) and wild-type (WT, +/+) mice. Heme oxygenase was expressed in both endothelial cells and glia of the injured cord. Barrier disruption to luciferase and infiltration of neutrophils were significantly greater in the HO-1+/- than WT mice at 24 h postinjury (P<or=0.019 and =0.049, respectively). We next examined by Western immunoblots the generation of 4-hydroxynoneal (HNE) and malondialdehyde (MDA), major products of lipid peroxidation, in the injured epicenter. There was a significant increase in 10 kDa HNE- and MDA-modified proteins in the HO-1+/- as compared with WT mice (P=0.037 and 0.043, respectively). Finally, we compared the degradation of myelin basic protein (MBP), an indicator of white matter damage, in the HO-1+/- and WT mice by Western immunoblots. There was significantly greater degradation of MBP in the HO-1+/- compared with WT mice (P=0.049). Together, these findings show that HO-1 modulates oxidative stress and white matter injury in the acutely injured spinal cord. This modulation may be partially attributed to the ability of HO-1 to stabilize the blood-spinal cord barrier and limit neutrophil infiltration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17047682     DOI: 10.1038/sj.jcbfm.9600412

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  31 in total

1.  Vascular Pathology as a Potential Therapeutic Target in SCI.

Authors:  Richard L Benton; Theo Hagg
Journal:  Transl Stroke Res       Date:  2011-11-29       Impact factor: 6.829

Review 2.  Targeting microvasculature for neuroprotection after SCI.

Authors:  Janelle M Fassbender; Scott R Whittemore; Theo Hagg
Journal:  Neurotherapeutics       Date:  2011-04       Impact factor: 7.620

3.  Nrf2 to pre-condition the brain against injury caused by products of hemolysis after ICH.

Authors:  Xiurong Zhao; Jaroslaw Aronowski
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

Review 4.  Spatial and temporal activation of spinal glial cells: role of gliopathy in central neuropathic pain following spinal cord injury in rats.

Authors:  Young S Gwak; Jonghoon Kang; Geda C Unabia; Claire E Hulsebosch
Journal:  Exp Neurol       Date:  2011-10-21       Impact factor: 5.330

5.  Protective effects of sulforaphane in experimental vascular cognitive impairment: Contribution of the Nrf2 pathway.

Authors:  Leilei Mao; Tuo Yang; Xin Li; Xia Lei; Yang Sun; Yongfang Zhao; Wenting Zhang; Yanqin Gao; Baoliang Sun; Feng Zhang
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-13       Impact factor: 6.200

Review 6.  Oxidative stress, DNA damage, and the telomeric complex as therapeutic targets in acute neurodegeneration.

Authors:  Joshua A Smith; Sookyoung Park; James S Krause; Naren L Banik
Journal:  Neurochem Int       Date:  2013-02-17       Impact factor: 3.921

Review 7.  Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

Authors:  Hemant Kumar; Alexander E Ropper; Soo-Hong Lee; Inbo Han
Journal:  Mol Neurobiol       Date:  2016-05-18       Impact factor: 5.590

Review 8.  Regulation of haeme oxygenase-1 for treatment of neuroinflammation and brain disorders.

Authors:  P J Syapin
Journal:  Br J Pharmacol       Date:  2008-09-15       Impact factor: 8.739

9.  Transcriptomic screening of microvascular endothelial cells implicates novel molecular regulators of vascular dysfunction after spinal cord injury.

Authors:  Richard L Benton; Melissa A Maddie; Christopher A Worth; Edward T Mahoney; Theo Hagg; Scott R Whittemore
Journal:  J Cereb Blood Flow Metab       Date:  2008-07-09       Impact factor: 6.200

Review 10.  The paradox of chronic neuroinflammation, systemic immune suppression, autoimmunity after traumatic chronic spinal cord injury.

Authors:  Jan M Schwab; Yi Zhang; Marcel A Kopp; Benedikt Brommer; Phillip G Popovich
Journal:  Exp Neurol       Date:  2014-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.